Alcon Expands Its Cell Therapy Ambitions With $550M Neurotech Pharma Acquisition

Alcon’s Neurotech Pharmaceuticals acquisition brings the rare vision disorder cell therapy Encelto as well as the platform technology that developed it. Last year, Alcon acquired a majority stake in Aurion Biotech, a startup developing a corneal cell therapy. The post Alcon Expands Its Cell Therapy Ambitions With $550M Neurotech Pharma Acquisition appeared first on MedCity…

Read More

Recently Released KFF Poll Shows Uncertainty Over Established Safety of COVID-19 Vaccines During Pregnancy – The Monitor

KFF’s recently released Tracking Poll finds that public confidence in the safety of COVID-19 vaccines for use during pregnancy has fallen, and many are uncertain about a false claim linking the vaccines with higher risk of miscarriage. Separately, conversations about childhood vaccines frame vaccination as an individual parental decision.

Read More

INVEST Digital Health Celebrates Healthcare Innovation in Texas

In addition to a packed conference agenda and tours of the Pegasus Park healthcare and life science innovation hub in Dallas, INVEST Digital Health also includes an innovation showcase with novel health tech and medtech offerings as well as networking opportunities. The post INVEST Digital Health Celebrates Healthcare Innovation in Texas appeared first on MedCity…

Read More

2026 Employer Health Benefits Survey

This is the 28th Employer Health Benefits Survey (EHBS) and reflects employer-sponsored health benefits in 2026. As in years past, the survey examines trends in employer coverage, including premiums, employee contributions, deductibles, offer rates, and employer practices. This year, we asked employers detailed questions about satisfaction with their health plans; coverage of GLP-1 agonists and…

Read More